180 related articles for article (PubMed ID: 32311048)
1. Clinical MEN-1 Among a Large Cohort of Patients With Acromegaly.
Nachtigall LB; Guarda FJ; Lines KE; Ghajar A; Dichtel L; Mumbach G; Zhao W; Zhang X; Tritos NA; Swearingen B; Miller KK; Thakker RV
J Clin Endocrinol Metab; 2020 Jun; 105(6):e2271-81. PubMed ID: 32311048
[TBL] [Abstract][Full Text] [Related]
2. Mutation analysis of MEN1, HRPT2, CASR, CDKN1B, and AIP genes in primary hyperparathyroidism patients with features of genetic predisposition.
Vierimaa O; Villablanca A; Alimov A; Georgitsi M; Raitila A; Vahteristo P; Larsson C; Ruokonen A; Eloranta E; Ebeling TM; Ignatius J; Aaltonen LA; Leisti J; Salmela PI
J Endocrinol Invest; 2009 Jun; 32(6):512-8. PubMed ID: 19474519
[TBL] [Abstract][Full Text] [Related]
3. Mutational and large deletion study of genes implicated in hereditary forms of primary hyperparathyroidism and correlation with clinical features.
Pardi E; Borsari S; Saponaro F; Bogazzi F; Urbani C; Mariotti S; Pigliaru F; Satta C; Pani F; Materazzi G; Miccoli P; Grantaliano L; Marcocci C; Cetani F
PLoS One; 2017; 12(10):e0186485. PubMed ID: 29036195
[TBL] [Abstract][Full Text] [Related]
4. Assessment of p27 (cyclin-dependent kinase inhibitor 1B) and aryl hydrocarbon receptor-interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations.
Igreja S; Chahal HS; Akker SA; Gueorguiev M; Popovic V; Damjanovic S; Burman P; Wass JA; Quinton R; Grossman AB; Korbonits M
Clin Endocrinol (Oxf); 2009 Feb; 70(2):259-64. PubMed ID: 18710468
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin analogues do not affect calcium metabolism in patients with acromegaly and primary hyperparathyroidism [corrected] due to MEN 1-like syndrome.
Bogazzi F; Lombardi M; Russo D; Sardella C; Raggi F; Brogioni S; Cetani F; Ceccarelli C; Mariani G; Basolo F; Martino E
Horm Metab Res; 2011 Feb; 43(2):126-9. PubMed ID: 20972944
[TBL] [Abstract][Full Text] [Related]
6. Possible association between Carney complex and multiple endocrine neoplasia type 1 phenotypes.
Nunes VS; Chang CV; Mazeto GM; Marques ME; Castro AV; Nogueira CR
Arq Bras Endocrinol Metabol; 2008 Nov; 52(8):1356-61. PubMed ID: 19169494
[TBL] [Abstract][Full Text] [Related]
7. Mutation analysis of the MEN1 gene in multiple endocrine neoplasia type 1, familial acromegaly and familial isolated hyperparathyroidism.
Teh BT; Kytölä S; Farnebo F; Bergman L; Wong FK; Weber G; Hayward N; Larsson C; Skogseid B; Beckers A; Phelan C; Edwards M; Epstein M; Alford F; Hurley D; Grimmond S; Silins G; Walters M; Stewart C; Cardinal J; Khodaei S; Parente F; Tranebjaerg L; Jorde R; Salmela P
J Clin Endocrinol Metab; 1998 Aug; 83(8):2621-6. PubMed ID: 9709921
[TBL] [Abstract][Full Text] [Related]
8. Multiple endocrine neoplasia type 1 syndrome: single centre experience from western India.
Goroshi M; Bandgar T; Lila AR; Jadhav SS; Khare S; Shrikhande SV; Uchino S; Dalvi AN; Shah NS
Fam Cancer; 2016 Oct; 15(4):617-24. PubMed ID: 26905068
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone-releasing hormone-producing pancreatic neuroendocrine tumor in a multiple endocrine neoplasia type 1 family with an uncommon phenotype.
Sala E; Ferrante E; Verrua E; Malchiodi E; Mantovani G; Filopanti M; Ferrero S; Pietrabissa A; Vanoli A; La Rosa S; Zatelli MC; Beck-Peccoz P; Verga U
Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):858-62. PubMed ID: 23542451
[TBL] [Abstract][Full Text] [Related]
10. Atypical clinical manifestations of multiple endocrine neoplasia type 1 syndrome.
Krysiak R; Kajdaniuk D; Marek B; Okopień B
Pol Arch Med Wewn; 2009 Mar; 119(3):175-9. PubMed ID: 19514648
[TBL] [Abstract][Full Text] [Related]
11. Functioning glucagonoma associated with primary hyperparathyroidism: multiple endocrine neoplasia type 1 or incidental association?
Erdas E; Aste N; Pilloni L; Nicolosi A; Licheri S; Cappai A; Mastinu M; Cetani F; Pardi E; Mariotti S; Pomata M
BMC Cancer; 2012 Dec; 12():614. PubMed ID: 23259638
[TBL] [Abstract][Full Text] [Related]
12. True MEN1 or phenocopy? Evidence for geno-phenotypic correlations in MEN1 syndrome.
Kövesdi A; Tóth M; Butz H; Szücs N; Sármán B; Pusztai P; Tőke J; Reismann P; Fáklya M; Tóth G; Somogyi A; Borka K; Erdei A; Nagy EV; Deák V; Valkusz Z; Igaz P; Patócs A; Grolmusz VK
Endocrine; 2019 Aug; 65(2):451-459. PubMed ID: 31044390
[TBL] [Abstract][Full Text] [Related]
13. Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia.
Georgitsi M; Raitila A; Karhu A; van der Luijt RB; Aalfs CM; Sane T; Vierimaa O; Mäkinen MJ; Tuppurainen K; Paschke R; Gimm O; Koch CA; Gündogdu S; Lucassen A; Tischkowitz M; Izatt L; Aylwin S; Bano G; Hodgson S; De Menis E; Launonen V; Vahteristo P; Aaltonen LA
J Clin Endocrinol Metab; 2007 Aug; 92(8):3321-5. PubMed ID: 17519308
[TBL] [Abstract][Full Text] [Related]
14. Clinical and genetic features of patients with multiple endocrine tumors who have neither family history nor MEN1 germline mutations.
Sakurai A; Katai M; Yumita W; Minemura K; Hashizume K
Endocrine; 2004 Feb; 23(1):45-9. PubMed ID: 15034196
[TBL] [Abstract][Full Text] [Related]
15. Acromegaly and late-onset primary hyperparathyroidism in a female with a rare MEN1 gene variant of yet undetermined clinical significance (p.Val167Ala).
Godlewska M; Bogusławska A; Nowak A; Skalniak A; Sowa-Staszczak A; Gilis-Januszewska A; Hubalewska-Dydejczyk A
Endokrynol Pol; 2020; 71(6):579-580. PubMed ID: 33125695
[TBL] [Abstract][Full Text] [Related]
16. Familial isolated primary hyperparathyroidism--a multiple endocrine neoplasia type 1 variant?
Miedlich S; Lohmann T; Schneyer U; Lamesch P; Paschke R
Eur J Endocrinol; 2001 Aug; 145(2):155-60. PubMed ID: 11454510
[TBL] [Abstract][Full Text] [Related]
17. Neurofibromatosis Type 1 with Concurrent Multiple Endocrine Disorders: Adenomatous Goiter, Primary Hyperparathyroidism, and Acromegaly.
Yasuda S; Inoue I; Shimada A
Intern Med; 2021; 60(15):2451-2459. PubMed ID: 34334593
[TBL] [Abstract][Full Text] [Related]
18. A kindred with a variant of multiple endocrine neoplasia type 1 demonstrating frequent expression of pituitary tumors but not linked to the multiple endocrine neoplasia type 1 locus at chromosome region 11q13.
Stock JL; Warth MR; Teh BT; Coderre JA; Overdorf JH; Baumann G; Hintz RL; Hartman ML; Seizinger BR; Larsson C; Aronin N
J Clin Endocrinol Metab; 1997 Feb; 82(2):486-92. PubMed ID: 9024241
[TBL] [Abstract][Full Text] [Related]
19. Novel germline variants of CDKN1B and CDKN2C identified during screening for familial primary hyperparathyroidism.
Mazarico-Altisent I; Capel I; Baena N; Bella-Cueto MR; Barcons S; Guirao X; Albert L; Cano A; Pareja R; Caixàs A; Rigla M
J Endocrinol Invest; 2023 Apr; 46(4):829-840. PubMed ID: 36334246
[TBL] [Abstract][Full Text] [Related]
20. Coincidence of multiple endocrine neoplasia types 1 and 2: mutations in the RET protooncogene and MEN1 tumor suppressor gene in a family presenting with recurrent primary hyperparathyroidism.
Frank-Raue K; Rondot S; Hoeppner W; Goretzki P; Raue F; Meng W
J Clin Endocrinol Metab; 2005 Jul; 90(7):4063-7. PubMed ID: 15870131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]